Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol after acute brain injury surgery
ChiCTR2400092859Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of landiolol in traumatic brain injury (TBI) (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: In-hospital mortality. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
landiolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR2400092859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092859.